Myeloma care adaptations in the UK during SARS‐CoV‐2 pandemic: Challenges and measurable outcomes-Reference-Cited by-同舟云学术

Myeloma care adaptations in the UK during SARS‐CoV‐2 pandemic: Challenges and measurable outcomes

Published:2020-07-15 Issue:5 Volume:105 Page:662-666
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur. J. Haematol.

Author:

Djebbari Faouzi¹^ORCID,Panitsas Fotios²,Sharpley Faye A.¹,Rampotas Alexandros¹,Larham Jemma¹,Moore Sally¹,Gooding Sarah¹,Kothari Jaimal¹,Ramasamy Karthik¹

Affiliation:

1. Department of Clinical Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK

2. Department of Haematology Laiko General Hospital Athens Greece

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13479

Reference20 articles.

1. Cancer and COVID-19: what do we really know?

2. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

3. Public Health England.Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID‐19. 2020. Available athttps://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. Last Accessed April 21 2020

4. Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy

5. British Society of Haematology (BSH).UK Myeloma Forum guidance to support medical decision‐making in the management of myeloma patients during the COVID‐19 (Coronavirus) outbreak. 2020. Available athttps://b-s-h.org.uk/media/18178/covid_19_ukmf_guidance_document_final_24th_march_2020.pdf. Last Accessed April 21 2020.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic;Blood Cancer Journal;2023-03-15

2. Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK);British Journal of Haematology;2020-12-16